Acarix AB (publ) (FRA:7AC)

Market Cap	31.65M +38.0%
Revenue (ttm)	680.18K +18.7%
Net Income	-4.44M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	250
Open	0.0197
Previous Close	0.0197
Day's Range	0.0197 - 0.0197
52-Week Range	0.0112 - 0.0448
Beta	n/a
RSI	56.17
Earnings Date	Apr 15, 2026

About Acarix AB

Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2009
• Employees: 8
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7AC

Financial Performance

In 2025, Acarix AB's revenue was 7.36 million, an increase of 18.69% compared to the previous year's 6.20 million. Losses were -48.09 million, -27.34% less than in 2024.

Financial numbers in SEK